Stellar performance leads to swathe of glowing research notes. Plus, Pilbara chief cites ‘incredibly strong’ long-term ...

Pursuant to the transaction with Telix, ImaginAb has retained its lead imaging candidate, CD8 ImmunoPET, which is currently in Phase 2 clinical trials and has been licensed by numerous pharmaceutical ...

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a ...

Brokers think these shares could be buys for income investors. Let's see what they are saying. The post Buy Telstra and this ...

The Aussie stock market will flirt with another record high at open, with ASX 200 futures pointing to a 0.34% gain up to a lofty 8,529 points. The local bourse has been quite nicely green all through ...

Quite a few insiders have dramatically grown their holdings in Corporate Travel Management Limited ( ASX:CTD ) over ...

Using the 2 Stage Free Cash Flow to Equity, MedAdvisor fair value estimate is AU$0.36. MedAdvisor is estimated to be 48% undervalued based on current share price of ...

According to a report by the Australian Bureau of Statistics (ABS) published on December 4, 2024, the Australian economy grew ...

Australian shares are set to open up. The Nasdaq was held back by a slump in Microsoft. ECB cuts key rate. Follow updates here.

Alterity Therapeutics (NASDAQ: ATHE) is making headlines today with an impressive 43.33% surge in its stock price, reaching $4.29 at 11:31 AM EST during Thursday’s trading session. This notable ...

Indonesia has cut nickel production quotas in a move Benchmark says could leave domestic smelters crying out for supply.

Sunshine Metals (ASX:SHN) is kicking off 2025 with major exploration breakthroughs at the Liontown Gold Project.